Table 6.

Demographic and Baseline Characteristics of Subjects From the US and the Rest of the World.

	US (N = 120)		ROW (N = 279)
	Sativex (n = 58)	Placebo (n = 62)	Sativex (n = 142)	Placebo (n = 137)
Age ≥65, n (%)	15 (26)	14 (23)	52 (37)	52 (38)
Average pain (mean)	6.2	6.4	5.5	5.5
Total opioid* (mean/median)	149/120	158/120	220/193	230/210
Maintenance	121/90	131/90	191/180	206/180
Breakthrough	29/5	27/3	29/16	25/10
Prior use of cannabis, n (%)	14 (24)	11 (18)	3 (2)	1 (1)

*morphine equivalence (mg).